🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study objective is to confirm appropriate use and safety profile of Pra...
Status
Completed
Location
Nippon Boehringer Ingelheim Co., Ltd
Start Date
2017-07-05
Trial ID
NCT03175198
Treatments Being Tested
The main purpose of REVLIMID® DUE (Drug Use Examination) is to collect and ...
Status
Completed
Location
Hallym University Sacred Heart Hospital
Start Date
2011-03-09
Trial ID
NCT02556905
Treatments Being Tested
A Non-Interventional, Post-Marketing Surveillance (NI-PMS) study whose obje...
Status
Completed
Location
Multiple Locations
Start Date
2006-09
Trial ID
NCT00843284
Treatments Being Tested
This randomized, double-blind, placebo-controlled clinical trial aims to in...
Status
Enrolling By Invitation
Location
the university of Jordan
Start Date
2025-11-01
Trial ID
NCT07310485
Treatments Being Tested
Hot flashes are the most common symptom of menopause and affect almost 75% ...
Status
Completed
Location
Changhua Christian Hospital
Start Date
2014-03-19
Trial ID
NCT02100540
Treatments Being Tested
Dietary supplementation is widely used to alleviate various symptoms of PMS...
Status
Completed
Location
Citruslabs
Start Date
2021-08-01
Trial ID
NCT05019924
Treatments Being Tested
The purpose of this experiment is to evaluate the efficacy of supplemental ...
Status
Unknown
Location
Kai-Li Liu
Start Date
2021-06-08
Trial ID
NCT05443477
Treatments Being Tested
Premenstrual syndrome (PMS) is a common condition that affects women of rep...
Status
Not Yet Recruiting
Location
San Francisco Research Institute
Start Date
2026-03-20
Trial ID
NCT07441096
Treatments Being Tested
This is a regulatory-required non-interventional pharmacovigilance study ex...
Status
Completed
Location
Multiple Locations
Start Date
2005-06
Trial ID
NCT01053429
Treatments Being Tested
To understand the incidence of ADRs of Calquence capsules 100 mg (acalabrut...
Status
Completed
Location
Research Site
Start Date
2023-06-19
Trial ID
NCT05665374